美瑞健康国际(02327.HK)出售上海健康管理服务股权 另收购深圳诊所权益
美瑞健康国际(02327.HK)公布,公司之间接全资附属美瑞健康服务出售La Clinique de Paris之60%已发行股本,总代价为2,520万元。另外,美瑞健康服务又收购柏瑞健康管理(公司之间接非全资附属之全部股权),总代价为720万元。
La Clinique de Paris主要於香港及上海从事提供健康管理服务。柏瑞健康管理则拥有深圳柏瑞诊所之80%股权,深圳柏瑞诊所主要於中国从事提供健康管理服务。
集团预期出售之可能收益约100万元,所得款项将用作集团之一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.